MedPath

Setting the Shortest Examination Time of Gastroscopy to Improve the Detection Rate of Upper Gastrointestinal Tumors

Not Applicable
Completed
Conditions
Gastroscopy Time
Early Gastric Cancer
Detection Rate
Interventions
Other: Set the minimum time of gastroscopy
Registration Number
NCT04602299
Lead Sponsor
Changhai Hospital
Brief Summary

This multicenter, prospective, interventional study aims to include 2000 gastroscopic procedures and investigate the relationship between procedure time and lesion detection rate in tertiary endoscopic centers in China. At the first stage, the researchers observe the actual procedure time of gastroscopies without affecting the natural behavior of endoscopists. At the second stage, a minimal time limit will be set for each procedure based on the observational results of the first stage. The primary study outcome is focal lesion detection rate. Secondary outcomes include detection rate of early upper GI cancer, biopsy rate and adverse event rate.

Detailed Description

China is a country with a heavy burden of gastric cancer and esophageal cancer. In 2015, the incidence/mortality of gastric cancer and esophageal cancer in China were 680000/500000 and 220000/200000, respectively. Gastroscopy is the most important means to detect early cancer of gastrointestinal tract. However, due to various factors, the miss rate of clinical significant lesions by gastroscopy is innegligible. Our previous research results showed that the detection rate of early gastric cancer and early esophageal cancer in China was only about 15%. This study aims to include 2000 gastroscopic procedures and investigate the relationship between procedure time and lesion detection rate in tertiary endoscopic centers in China.

At the first stage, the researchers observe the actual procedure time of gastroscopies without affecting the natural behavior of endoscopists. Then, researchers collect the data (including focal lesion detection rate, procedure time, detection rate of early upper GI cancer, biopsy rate and adverse event rate) and analyze the minimal procedure time. At the second stage, a minimal time limit will be set for each procedure. Every stage last two months, and potential correlations between lesion detection rate and procedure time will be investigated through subsequent statistical analysis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • No history of benign and malignant tumors (including carcinoma and adenoma) of upper GI (including esophagus, stomach and duodenum)
  • undergo gastroscopy with intravenous anesthesia (or conscious sedation)
Exclusion Criteria
  • Subjects with focal lesions detected by gastroscopy within 1 year
  • Subjects that cannot stand the gastroscopy procedure or cannot cooperate with endosccopists
  • Emergency endoscopy and therapeutic endoscopy
  • Subjects with history of esophageal or stomach surgery or endoscopic surgery
  • Pregnant
  • Subjects that taking antiplatelet or anticoagulant drugs which contradicts endoscopic biopsy
  • Subjects with other serious complications that affect the speed of gastroscopy
  • Subjects that refuse to cooperate with data collection or sign the informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Set the minimum time of gastroscopySet the minimum time of gastroscopy-
Primary Outcome Measures
NameTimeMethod
focal lesion detection ratetwo months

number of gastroscopy procedures that detects focal lesions divided by the number of all gastroscopy procedures

Secondary Outcome Measures
NameTimeMethod
detection rate of neoplastic lesionstwo months

number of gastroscopy procedures that detect upper GI cancers divided by the number of all gastroscopy procedures

mean (median) examination time for normal EGDs without biopsytwo months

mean (median) examination time for all normal EGDs without biopsy

rate of procedures reaching the minimal timetwo months

number of gastroscopy procedures that reach the minimal time divided by the number of all gastroscopy procedures

detection rate of high risk lesionstwo months

number of gastroscopy procedures that detect upper GI cancers (gastric or esophageal cancer), dysplasia and intestinal metaplasia divided by the number of all gastroscopy procedures

endoscopic biopsy ratetwo months

number of gastroscopy procedures with biopsy divided by the number of all gastroscopy procedures

Trial Locations

Locations (2)

Changhai Hospital

🇨🇳

Shanghai, China

Changhai Hospital, Second Military Medical University

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath